Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 31c, Revenues Beat; Boosts FY18 EPS, Sales Growth Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Avanos Medical, Inc. Announces Second Quarter 2018 Results, Raises Full-Year 2018 Outlook
August 7, 2018 7:00 AM EDTALPHARETTA, Ga., Aug. 7, 2018 /PRNewswire/ --Â Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2018 results, raised its full-year 2018 Medical Device net sales expectations and adjusted diluted earnings per share outlook.
"I'm pleased to announce another strong quarter with 7 percent organic top-line growth driven by continued strength in Coolief and Chronic Care," said Joe Woody,... More
